Multiple Myeloma in Relapse Recruiting Phase Trials for Carfilzomib (DB08889)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02970747Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone in Multiple Myeloma Patients